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Abstract Several protein kinase C (PKC) isozymes were ana- 
lyzed by immunoblot and immunocytochemistry in cultures of 
hippocampal neurones at several stages of differentiation. Our 
findings reveal the existence of two distinct patterns of expres- 
sion. Firstly, conventional PKC isozymes a, /3 and % that are 
expressed at very low levels during the initial stages and then 
increase continuously with time of culture. Secondly, novel PKC 
isozymes 6, ~ and 5, whose contents increase very early to reach 
a maximum after three days of culture and then progressively 
decline. Specific proteolysis for PKC isozymes i~ and y was 
observed throughout he period studied. The developmental pro- 
file obtained for the different PKC isozymes is discussed in rela- 
tion to the differentiation of hippocampal neurones in culture. 
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I. Introduction 
Protein kinase C (PKC) is a family of serine/threonine ki- 
nases composed of at least 10 distinct isozymes, including con- 
ventional PKC's (~, ill, flu and 79 and novel PKC's (~, e, (, r/, 
0 and A,). Their role as mediators of signals generated upon 
external stimulation by hormones, neurotransmitters and 
growth factors has been widely and profusely documented (for 
recent reviews ee [1-3]). In the brain, PKC's are highly concen- 
trated and have been implicated in a broad spectrum of neu- 
ronal functions, such as modulation of ion channels [4], recep- 
tors [5] and neurotransmitter r lease [6]. PKC activation has 
also been implicated in the initiation and maintenance of Long 
Term Potentiation (LTP) [7,8] and Long Term Depression 
(LTD) [9]. 
During the last years, increasing evidence has accumulated 
suggesting a differential involvement of PKC isozymes in spe- 
cific cellular functions, based on their different expression 
[10,11], substrate specificity [12], subcellular localization [13] 
and ability to interact with other cellular components [lZV16]. 
Immunohistochemical studies using isozyme-specific antibod- 
ies in the rat brain have revealed that the distribution and 
subcellular localization of PKC isozymes varies greatly among 
anatomical regions [17-19] and can be selectively modified by 
treatments in vivo [20,21]. Very often, changes in the amount 
and activity of PKC have been implicated in the initiation of 
neuronal differentiation. However, the contribution of the dif- 
ferent PKC isozymes to this process is not well understood. 
Most of our current knowledge comes from studies performed 
in cell lines such as PC12 [22,23], NG108-15 [24] and C6 glioma 
*Corresponding author. Fax: (34) (1) 397 8344. 
[25], where the expression pattern of PKC isozymes i  different 
from the situation in vivo. 
Primary cultures of hippocampal neurones derived from rat 
embryos constitute an adequate preparation to study neuronal 
development and function at the molecular and cellular level. 
They provide a highly homogeneous population of neurones of 
the pyramidal type which spontaneously display a well char- 
acterised program of development during the time of culture 
[26]. Several authors have stressed the importance of PKC in 
mediating survival-promoting and neurite outgrowth effects of 
various growth factors and other treatments on these cultures 
[27]. In the present work, we analyze the content and localiza- 
tion of several PKC isozymes during the development of hip- 
pocampal neurones in culture. Our findings reveal the existence 
of two distinct patterns of expression. Conventional PKC 
isozymes (a, fl and y) express very low levels during the initial 
stages and after two or three days in culture increase in content 
continuously. On the other side, novel PKC isozymes (g, e and 
() increase arly to reach a maximum after three days of culture 
and then progressively decline. We discuss these results in rela- 
tion to the process of neuronal differentiation that takes place 
in these cultures. 
2. Materials and methods 
2.1. Mater&& 
Rabbit polyclonal antibodies against peptide sequences unique to 
isozymes co, t, ~,, ~, e and ~ of PKC were obtained from Gibco-BRL. 
Antibody 150 (mouse, IgM) recognizes mode-I phosphorylated Micro- 
tubule-Associated Protein 1B (MAPIB) [28]. Antibody AP14 (mouse, 
IgG) recognizes the high molecular weight isoforms of Microtubule- 
Associated Protein 2 (MAP2). PMA (phorbol 12-myristate 13-acetate) 
was from Sigma. Stock solutions of PMA (× 100 and x 1000) were 
prepared in DMSO and maintained at -20 ° until use. 
2.2. Cell culture and preparation of cell extracts 
Cultures of hippocampal neurones were prepared as described first 
by Banker and Cowan [29] and then modified by Goslin and Banker 
[30]. In brief, 18 days old rat embryos were used, their hippocampi 
removed and trypsinized for 15 min. After mechanical disruption i  the 
presence of DNase I and soybean trypsin inhibitor, the cells were 
counted and seeded on poly-e-lysine coated plastic dishes at a density 
of 30.000 cells/cm z in 10% FCS/DMEM. Three hours later, culture 
medium was removed and substituted by DMEM-based N2 medium 
[31], supplemented with 1 mM pyruvate and 1 mg/ml egg albumin. In 
order to reduce pH fluctuations, odium bicarbonate was lowered to 
0,85 g/l and iso-osmotically substituted by HEPES pH 7,3. One-third 
of the culture medium was replaced by fresh medium after one week 
in culture. Cell extracts were prepared in ice-cold buffer containing 20 
mM Tris-HCl, pH 7.5, 2 mM EDTA, 0.5% Triton X-100, 10 pg/ml 
Aprotinin, 10 pg/ml Leupeptin, 10 pg/ml Pepstatin and 1 mM PMSF 
and homogenised using a sterile syringe with 23-G needle. The homoge- 
nates were centrifuged at100,000 x g for 30 min at 4 ° and the superna- 
tants were used irectly for analysing the content of PKC isozymes by 
immunoblot. Total protein content was determined bythe BCA method 
[32]. 
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2.3. Immunoblot analys& 
Triton X-100 extracts from hippocampal neurones were denatured 
in Laemmli solution and subjected to SDS-PAGE in minigels (8% 
polyacrylamide) [33]. A sample of adult rat brain extract was always 
included in each blot. Protein was transferred to PVDF membranes for 
90 min at 50 V in a semi-dry electrotransfer device. The membranes 
were incubated successively with 3% bovine serum albumin (BSA) in 
phosphate buffered saline (PBS) for 1 h, with rabbit antibodies to PKC 
isozymes (c~, fl, ?', & e and O diluted 1 : 1000 in PBS, 0.05% Tween 20 
(PBS/T20) for 18h and with peroxidase-conjugated anti-rabbit lgG 
antibody (Affinity) diluted 1 : 2000 in PBS/T20. Following each incuba- 
tion, the membranes were extensively washed ( x 5) with PBS/T20. The 
immunoreactive bands were visualised using diaminobenzidine/H202 in 
PBS with Nickel-Cobalt enhancement aspreviously described [34]. 
2.4. Immunocytochemistry 
For immunocytochemistry, hippocampal neurones were plated on 
poly-L-lysine-coated glass coverslips at 15.000 cells/cm 2. To maintain 
the viability of the neurones at such low density, coverslips with neu- 
rones attached were placed on multiwell dishes with the neurones facing 
down to the bottom of the well as previously described [35]. At different 
times of culture, hippocampal neurones were fixed with 4% paraformal- 
dehyde in PBS for 20 min at room temperature and washed thoroughly 
with PBS. All subsequent incubations were done at room temperature. 
The coverslips were successively incubated with 1 mg/ml sodium 
borohydride (NaBH4) in PBS (2 x l0 min), with 3% BSA, 0.2% Triton 
X-100 in PBS (30 rain), with 10% horse serum, 0.2% Triton X-100 in 
PBS (HS Buffer) (30 min), with rabbit antibodies to PKC isozymes (~, 
fl, e and 0 diluted 1:100 in HS Buffer (120 min), with biotinylated 
anti-rabbit antibody (Vector) diluted 1 : 200 in HS buffer (60 min) and 
with ABC reagent (Vector) in HS buffer (60 rain). Following each 
incubation, the coverslips were extensively washed with PBS/T20. De- 
velopment of immunoreactivity was visualised at the light microscope 
using diaminobenzidine/H202 in PBS. Negative controls were done by 
omitting the primary antibody. For immunofluorescence, overslips 
were blocked and permeabilized as described above and sequentially 
incubated with antibody AP14 (1 : 10), anti-mouse IgG Texas red-con- 
jugated (DAKO), antibody 150 (1:10) and anti-mouse IgM Fluores- 
cein-conjugated (DAKO). Coverslips were mounted in Mowiol. 
3. Results 
Primary cultures of hippocampal neurones are a suitable 
preparation to study the expression and subcellular localization 
of neuronal proteins. Hippocampal neurones obtained from 
El8 rats readily adhere to the culture substratum and initiate 
the extension of cytoplasmic processes that will further mature 
into axon and dendrites. Interestingly, axonal and dendritic 
outgrowth proceed with different timings and ratios. Thus, 
axonal elongation starts typically after 36 hours of culture and 
proceeds very quickly. On the other hand, dendritic outgrowth 
starts after 4 days in culture and proceeds much more slowly 
[26]. Fig. 1 illustrates this typical behaviour. Hippocampal neu- 
rones cultured for 2 days (T2) are actively extending an axon- 
like process, as revealed by an antibody that recognizes mode-I 
phosphorylated MAP1B (T2, MAP1B-P). On the other hand, 
after ten days of culture (T10), neurones have already develop 
a network of axons (T10, MAP1B-P) and their dendrites have 
entered the maturation stage, as revealed by antibodies that 
recognize high-molecular weight MAP2 (T10, hMAP2). 
In order to characterize the presence and timing of expres- 
sion of PKC isozymes in hippocampal neurones in culture, 
Triton X-100 extracts obtained at different times of culture 
(T0-T10) were analyzed by immunoblot (Fig. 2). The levels 
r ¸;~ i ~ i l  ~ :~ ~> 
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Fig. 1. Characterization f the cultures of hippocampal neurones. Hippocampal neurones grown on coverslips for two days (T2) or ten days (T10) 
were fixed and processed for double-immunofluorescence with antibody 150 which recognizes mode-I phosphorylated MAP1B (MAP1B-P) and 
antibody AP14 which recognizes high molecular weight isoforms of MAP2 (hMAP2). Neurites labelled with antibody 150 (MAP1 B-P) and not with 
antibody AP14 (hMAP2) represent axons, whereas neurites labelled with both antibodies AP14 (hMAP2) and 150 (MAP1B-P) represent dendrites. 
Scale bars = 50/zm. 
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measured for PKC~ were very low and only detectable after 
2 days in culture. The relative abundance of this isozyme in- 
creased with the time of culture, reaching maximum levels at 
10 days. No immunoreactive bands of the molecular weight 
expected for PKC/3 and PKCy were found. Instead, one band 
migrating at approximately 68kDa was encountered for PKCfl 
and two bands migrating at approximately 72and 60 kDa were 
found for PKCy. In both cases, the amount of immunoreactiv- 
ity increased with the time of culture. On some occasions, 
immunoreactive bands with similar migration values (68 kDa 
for PKC/3 and 60 and 72 kDa for PKCy) were found in rat 
brain extracts, suggesting that proteolytic degradation could 
have taken place. To rule out the possibility that proteolysis 
had occurred during the extraction process, an extraction 
buffer containing 1% SDS, 1 mM EDTA, 50 mM Tris-HC1, pH 
7,4 heated at 90°C was used. Under these conditions, im- 
munoblots for PKC/3 and PKC~' were identical to those ob- 
tained with Triton X-100 extracts. Novel PKC isozymes e, 6 
and ( exhibited a bell-shaped developmental profile. Their con- 
centration increased since the onset of the cultures to reach 
maximum levels between two and three days in culture 
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Fig. 2. lmmunoblot analysis of PKC isozymes present in hippocampal 
neurones at several times in culture. Hippocampal neurones were ex- 
tracted as described insection 2after 2 hours (TO), one day (T1), 2 days 
(T2), three days (T3), seven days (T7) and ten days (T10) in culture. 
Aliquots from adult rat brain extract were run in parallel for each 
isozyme (CONTROL). 10 pg of total protein was loaded in each lane. 
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Fig. 3. Down-regulation f PKC isozymes present in hippocampal 
neurones by phorbol ester treatment. Hippocampal neurones cultured 
for seven days were treated with 0.5 pM phorbol 12-myristate 13- 
acetate (PMA) or an equivalent volume of DMSO (CONTROL) for 18 
hours and then extracted and analysed by immunoblot as described in
section 2.15/~g of total protein was loaded in each lane. Arrows on the 
right of the blots indicate the migration position of the corresponding 
PKC isozyme in an extract from adult rat brain that was run in parallel. 
(T2-T3). Then, a progressive decay in their content extended 
until the latest ime studied. 
To further characterise the identity of the immunoreactive 
bands, down-regulation experiments of PKC isozymes were 
carried out. It is well known that long-term treatment with 
phorbol esters (PMA) accelerate he proteolytic degradation of
PKC isozymes c~, fl, y, e and 6, but not PKC~" [25,36]. Fig. 3 
shows that PMA treatment readily down-regulated PKC~, 
PKCe and PKC6, but not PKC( which served as positive 
control. Both the PKCfl-related 68 kDa band and the PKCy- 
related 72 kDa band disappeared after PMA treatment. How- 
ever, PKCy-related 60 kDa band did not exhibit down-regula- 
tion and probably bears no relationship with PKCy. 
The distribution and subcellular localization of PKC 
isozymes c~,/3, ~ and ( in cultures of hippocampal neurones was 
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Phase Contrast Bright Field 
neurites, during the early stages of development (Fig. 4 - T2, 
PKCfl). PKCe and PKC( immunoreactivity is better visualized 
at 2 days of culture, being clearly present in all neurites, either 
axon-like or dendrite-like ones (Fig. 5 - T2, PKCe and PKC(). 
Later on, the immunoreactivity for these isozymes decreases in
the neurites and restricts more to the cell bodies (Fig. 5 - TI0, 
PKCe and PKC(). These observations may reflect he different 
timing and rate of expression among PKC isozymes rather than 
a compartmentalization phenomenon. 
4. Discussion 
We have investigated the localization and abundance of sev- 
eral PKC isozymes in hippocampal neurones during their de- 
velopment in culture. Distinct development profiles have been 
observed for conventional (Ca2+-dependent) and novel (Ca 2+- 
independent) PKC isozymes during neuronal differentiation. 
PKC isozymes ~, fl and ~" increased in content continuously 
during the whole period of culture. However, PKC isozymes 
g, d and ( increased in content to reach a maximum at about 
two or three days of culture and then declined until the 10th 
Phase Contrast Bright Field 
Fig. 4. Immunolocalization of PKCa and PKCfl in cultured hippocam- 
pal neurones. Hippocampal neurones grown on coverslips for two days 
(T2) or ten days (T10) were fixed and processed for immunocytochem- 
istry with antibodies to PKC~ (upper panel) or PKCfl (lower panel). 
Phase contrast micrographs, showing neuronal morphology, are pre- 
sented on the left side of the panels and the corresponding bright field 
micrographs, showing only immunostaining, arepresented on the right 
side of the panels. Scale bar = 50/zm. 
analyzed by immunocytochemistry. PKCT/and PKC~ were ex- 
cluded of this study since the available antibodies recognised 
more than one band by immunoblot. No evidence could be 
obtained in support of a differential distribution of PKC 
isozymes into the axonal and/or dendritic ompartments of 
fully devel0i0ed neurones. Figs. 4 and 5 show representative 
samples chosen from hippocampal neurones cultured for 2 days 
(T2) and 10 days (T10). It must be emphasized that, for most 
isozymes, the highest degree of staining was found in the per- 
inuclear region. This pattern of staining is totally absent during 
the first hours of culture, only partially present at day 1 of 
culture and especially evident at later stages of culture (Fig. 4 
- T10, PKCfl). PKC~z and PKCfl are more clearly detected in 
neurones after 10 days of culture (Fig. 4 - T10, PKC~ and 
PKCfl). The immunoreactivity concentrates mostly in the per- 
inuclear egion - especially PKC~ - with less but still visible 
staining in the neurites. Both isozymes, but more particularly 
PKCfl, showed very low levels of immunostaining which made 
difficult to confirm their presence in the thinner, axon-like, 
~Y 
Fig. 5. Immunolocalization of PKCe and PKCff in cultured hippocam- 
pal neurones. Hippocampal neurones grown on coverslips for two days 
(T2) or ten days (T10) were fixed and processed for immunocytochem- 
istry with antibodies to PKCe (upper panel) or PKC( (lower panel). 
Phase contrast micrographs, howing neuronal morphology, are pre- 
sented on the left side of the panels and the corresponding bright field 
micrographs, showing only immunostaining, are presented on the right 
side of the panels. Scale bar = 50/zm. 
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day of culture. Immunocytochemical studies with PKC 
isozymes ~, fl, e and ~" did not show specific ompartmentaliza- 
tion either in the axon or the dendrites. 
The search for a correlation between euronal differentiation 
and PKC activity has long deserved particular attention in the 
literature. However, despite the efforts that have been made, 
no clear agreement has been reached onto whether an increase 
or a decrease of PKC activity is associated to neuronal differen- 
tiation. Down-regulation r inhibition of PKC activity has been 
associated to initiation of neuronal differentiation i  N2A neu- 
roblastoma cells [37] and SH-SY5Y neuroblastoma cells [38- 
40]. Also, dibutyryl cAMP-induced ifferentiation of NG108- 
15 cells is accompanied by a decrease in PKC~z [24]. On the 
other hand, PKC activity present in LAN-5 cells increased 
when differentiated with y-interferon [41] and differentiation f
NT2/D1 cells by retinoic acid is accompanied by an increase in 
PKC [42]. Lastly, PC12h cells differentiated with dibutyryl 
cAMP showed increased levels of PKCfl and decreased levels 
of PKC~ [43] whereas PKC~ content of PC12 cells is un- 
changed by treatment with nerve growth factor (NGF) [36]. It 
must be considered that all of these studies have been done in 
cell lines of neural origin and that neuronal differentiation was 
achieved by the addition of exogenous factors or compounds. 
Given the different developmental profiles observed for con- 
ventional and novel PKC isozymes, it would be tempting to 
speculate that axonal development is associated to the activity 
of novel PKC isozymes and dendritic maturation is associated 
with the activity of conventional PKC isozymes. We had previ- 
ously demonstrated that the third day of culture is a critical 
time for the development of hippocampal neurones in vitro, 
since a change in the phosphorylation pattern of microtubule 
associated protein 2 (MAP2) - a PKC substrate - occurs at that 
time [44]. In the present study, most PKC isozymes did not 
show specific subcellular compartmentalization during in vitro 
development. Only PKCfl showed such low levels of im- 
munostaining that its presence in thinner axon-like neurites 
could not be confirmed. So, if this is the case, one could suggest 
that isozyme compartmentalization is not a relevant feature for 
PKC action during neuronal differentiation i  vitro, but rather 
the timings and levels of expression for each isozyme. However, 
this in vitro observation contrasts with the in vivo situation of 
the adult hippocampus, where a defined subcellular localization 
exists for each PKC isozyme [17-19,45]. Similar puzzling results 
have been obtained before in primary cultures of rat cerebellum 
where neither the expression of different isozymes to different 
cell populations nor the subcellular localization observed in 
adult cerebellum is achieved in vitro [46]. It may be that addi- 
tional signals, probably of extracellular origin, are needed to 
determine PKC isozyme subcellular localization. 
Immunoreactive bands of 68 kDa for PKCfl and of 72 and 
60 kDa for PKCy were detected by immunoblot of hippocam- 
pal neurones extracts. We propose that 68 kDa peptide (PKCfl) 
and 72 kDa peptide (PKCy) represent proteolytic fragments of 
PKCfl and PKCy. These peptides are recognized by isozyme- 
specific antibodies, down-regulated by phorbol ester treatment 
and detected occasionally on immunoblots of adult rat brain 
extracts. Further, previous studies had already reported that 
PKCfl and PKCy exhibit a greater sensitivity to proteolysis 
than other PKC isozymes [47]. The question ow arises on to 
whether proteolysis occurs in situ or during the extraction pro- 
cedure. We favour the former possibility for several reasons. 
Firstly, a cocktail of proteases inhibitors was used throughout 
the extraction procedure. Secondly, proteolysis did not extend 
to other PKC isozymes assayed in the same extracts. Lastly, 
direct extraction with hot buffers containing SDS did not im- 
prove the recovery of intact PKCfl and PKCy. 
Proteolytic degradation of PKC isozymes by calpains has 
been shown to render a fragment of 36 kDa containing the 
regulatory element of the kinase and a second fragment of 
45-48 kDa containing the catalytic moiety, which is referred as 
PKM [48]. In hippocampal neurones extracts, immunoreactive 
bands for PKCfl and PKCy exhibited higher molecular weights 
than those expected for calpain fragments. Nonetheless, we can 
not exclude the possibility that they may represent true PKM 
fragments since the migration values that we obtained for intact 
PKCfl and PKCy from rat brain are in the range of 90-100 
kDa, slightly higher than those reported in the literature [2]. 
Alternatively, they could represent intermediate products of 
protease degradation. These products would contain the cata- 
lytic domain which is down-regulated by phorbol ester treat- 
ment, the V3 region -the antibodies used were raised against 
peptides of the V3 region- and probably the C2 domain which 
confers Ca2+-dependence. Proteolytic activation and degrada- 
tion of PKC isozymes has been widely discussed as a physiolog- 
ical mechanism to regulate the activity and localization of PKC 
isozymes. Tryptic activation of PKCe increased the kinase ac- 
tivity towards histone about 10-fold [49], Also, Suzuki et al. [50] 
have shown that PKCfl and PKCy isozymes are selectively 
associated with postsynaptic densities obtained from rat hip- 
pocampus and suggest that proteolytic activation of these 
isozymes could be a step in postsynaptic signal processing. It
may be therefore possible that PKCfl and PKCy present in 
hippocampal neurones in culture are subject o specific regula- 
tion by in vivo proteolysis. 
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